Contamination Tests After Radionuclide Therapy Applied to Thyroid and Prostate Cancer Patients
Advances in Medical Pyhsics and Applied Sciences · 2025
DOI: 10.63187/ampas.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Medical Pyhsics and Applied Sciences, 2025. Verfasst von Sinem Akyol und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose
Radiation exposure and potential risks in nuclear medicine clinics are critical concerns for both patients undergoing treatment and the healthcare staff. This study aims to investigate the radiation risks for patients receiving radioactive iodine (131I) and 177Lu PSMA therapy during their isolation period in the hospital. Materials and Methods: In this study, contamination measurements were conducted in rooms of thyroid and prostate cancer patients treated with 131I and 177Lu PSMA in our Nuclear Medicine clinic. The tests performed on thyroid and prostate cancer patients were conducted in two phases: prior to and subsequent to the cleaning of the room, immediately following the patients' discharge.
Findings
In the evaluation of sample counts, the average counts per minute (cpm) for 131I and 177Lu gamma counters were 217.6±136.7 cpm and 457.3±428.1 cpm, respectively. In the inhalation contamination test, discharge doses were
Zitieren
APA
Akyol, S., Çırka, Ş., Çelik, S., Yeyin, N., & Demir, M. (2025). Contamination Tests After Radionuclide Therapy Applied to Thyroid and Prostate Cancer Patients. Advances in Medical Pyhsics and Applied Sciences. https://doi.org/10.63187/ampas.2
Vancouver
Akyol S, Çırka Ş, Çelik S, Yeyin N, Demir M. Contamination Tests After Radionuclide Therapy Applied to Thyroid and Prostate Cancer Patients. Advances in Medical Pyhsics and Applied Sciences. 2025. doi:10.63187/ampas.2
BibTeX
@article{Akyol2025,
author = {Akyol, Sinem and Çırka, Şeyda and Çelik, Sinem and Yeyin, Nami and Demir, Mustafa},
title = {Contamination Tests After Radionuclide Therapy Applied to Thyroid and Prostate Cancer Patients},
journal = {Advances in Medical Pyhsics and Applied Sciences},
year = {2025},
doi = {10.63187/ampas.2}
}
EUVIMED